Intravenous Versus Peribulbar Dexmedetomidine for Strabismus Surgery in Adults
Status:
Not yet recruiting
Trial end date:
2022-06-20
Target enrollment:
Participant gender:
Summary
Using various adjuvants has become a trend in regional anesthesia practice to improve the
quality of anesthesia and prolong postoperative analgesia. Dexmedetomidine, an alpha-2
agonist has been proposed as a safe and effective adjunct capable of extending the duration
of the single-shot block